r Contraction-mediated blunting of postjunctional α-adrenergic vasoconstriction (functional sympatholysis) is attenuated in skeletal muscle of ageing males, brought on by altered postjunctional α 1 -and α 2 -adrenergic receptor sensitivity. The extent to which postjunctional α-adrenergic vasoconstriction occurs in the forearms at rest and during exercise in postmenopausal women remains unknown.
Introduction
Active skeletal muscles require an optimal matching of local blood flow to meet the functional and metabolic demand of the exercising muscle. This matching of local blood flow to metabolic demand of contracting skeletal muscle is highly regulated by numerous mechanisms. Neural mechanisms are one important factor in circulatory function during exercise. Moreover, discharge of sympathetic nerves innervating the vasculature elicits vasoconstriction both at rest and during exercise (Seals & Victor, 1991; Thomas & Segal, 2004; Fadel, 2015) . Vasoconstrictor tone within skeletal muscle is primarily controlled by α-adrenergic (α 1 and α 2 ) receptors located postjunctionally on smooth muscle . However, within contracting skeletal muscle α-adrenergic receptor responsiveness to increased sympathetic outflow is reduced, such that blood flow and oxygen delivery is proportional to the metabolic demand . This blunting of sympathetic vasoconstriction in the presence of 'metabolic' substances within contracting muscle is termed functional sympatholysis (Remensnyder et al. 1962) . Thus, the role of functional sympatholysis in optimizing local blood flow during physical activity is important in the context of functional work capacity and blood pressure regulation in humans.
Advancing age is associated with a progressive increase in sympathetic nervous system (SNS) activity and plasma noradrenaline concentrations subsequently increasing peripheral vascular resistance and vasoconstriction at rest and during exercise (Sundlof & Wallin, 1978; Narkiewicz et al. 2005; Smith et al. 2007; Best et al. 2014; Hearon & Dinenno, 2016) . One manifestation of advancing age is impaired functional sympatholysis and metabolic dysfunction in the active skeletal muscle tissue, which has been hypothesized to be brought on by impaired modulation and/or downregulation of signalling pathways closely related to postjunctional α-adrenergic (α 1 and α 2 ) receptors (Dinenno et al. 2002 (Dinenno et al. , 2005 Dinenno & Joyner, 2006; Hearon & Dinenno, 2016) . Along these lines, older healthy males demonstrate a reduced sympatholysis in response to intra-arterial infusions of α 1 -and α 2 -adrenergic agonists during handgrip exercise when compared to young males (Dinenno et al. 2005; Kirby et al. 2008 Kirby et al. , 2011 .
Importantly, postmenopausal women (PMW) experience a greater age-associated increase in SNS activity and vasoconstrictor tone as compared to ageing males (Moreau et al. 2003; Hart et al. 2009; Moreau & Ozemek, 2017) which may explain why this population experiences greater cardiovascular morbidity and mortality than ageing males (Joyner et al. 2016; Moreau & Ozemek, 2017) . In line with this notion, Parker et al. (2007aa, 2008 provided evidence of an age-sex interaction regarding vasoconstrictor tone and regulation of peripheral vascular resistance by demonstrating that PMW, but not older men, exhibit a blunted hyperaemic and vasodilatator response relative to their younger counterparts during reactive (ischaemia-induced) hyperaemia in the calf in combination with a vasoconstrictor stimulus (i.e. cold pressor test) (Parker et al. 2007aa) and during graded leg exercise (Parker et al. 2008) . Furthermore, Fadel et al. (2004) identified a reduced ability of handgrip exercise to blunt sympathetic vasoconstriction (measured via near-infrared spectroscopy) during acute sympathetic stimulation (via lower body negative pressure) in the exercising forearm of PMW compared to young women (YW). However, this study was not specifically designed to investigate whether blood flow and vascular conductance is indeed altered during exercise under acute sympathetic stimulation in PMW. Additionally, it remains unknown which postjunctional α-adrenergic receptor, if any, differentially alters functional sympatholysis within the ageing forearm of PMW compared to YW.
The primary purpose of the present investigation was to examine postjunctional α-adrenergic receptor responsiveness during exercise in older PMW compared to YW. We hypothesized that older PMW would demonstrate a reduced ability to attenuate α 1 -and α 2 -adrenergic vasoconstriction during forearm exercise (i.e. greater impairment in functional sympatholysis) as compared to YW. As no information exists regarding postjunctional α-adrenergic responsiveness at rest between PMW and YW, we further examined postjunctional α 1 -and α 2 -adrenergic vasoconstriction under resting conditions with age in women.
Methods

Ethical approval
The nature, risks and benefits of all study procedures were explained to the subjects, and their written informed consent was obtained before participation in the study. All procedures were reviewed and approved by the Institutional Review Board at the University of Iowa. The study conformed to the standards set by the Declaration of Helsinki, except for registration in a database.
Participants
Sixteen healthy women (YW, n = 8; older PMW, n = 8) participated in this investigation. All participants were labelled as non-obese (body mass index < 30 kg m −2 ), and were free of any cardiovascular, metabolic, autonomic or musculoskeletal disorders, and were not taking medications that may alter blood pressure responses as per a pre-screening questionnaire form. PMW enrolled in the study were not receiving hormone replacement therapy. Postmenopausal status was defined as > 12 months since last menstrual period and the average number of postmenopause years was 12 ± 3 years. YW were studied in the early follicular phase or placebo phase of oral contraceptive. The study was performed in the morning after an overnight fast, and subjects refrained from exercise, alcohol and caffeine for 24 h before reporting to the laboratory.
Experimental overview
Figure 1 is a schematic of the overall experimental design. We used a randomized counterbalanced study design to evaluate blood flow and vascular conductance responses to forearm contractions under intra-arterial administration of α-adrenergic agonists (α 1 vs. α 2 ) simultaneous to beta (β) blocker administration. After a preliminary testing and familiarization session (conducted on a separate day), subjects reported to the laboratory for the experimental testing session Subjects were studied while lying supine, with the left arm perpendicular to the body (ß80°) and in a dependent position just above heart level to avoid gravitational influences on blood flow at rest and during exercise. All study visits began with rest trials which consisted of a 2-min baseline period leading into 3 min of selective α 1 -(phenylephrine, PE) or α 2 -(dexmedetomidine, DEX) adrenergic receptor agonist administration to achieve a vasoconstrictor stimulus (drug order randomized). Subsequently, either high flow via adenosine (ADO) infusion or exercise trials (which were randomized) was conducted. Each trial began with a 2-min baseline period, followed by either 3 min of exercise or ADO infusion to achieve a steady state (SS) blood flow response. After 3 min of high flow or forearm exercise, either PE or DEX was administered for the remaining 3 min. The order of ADO and exercise trials as well as drug administration (PE or DEX) was randomized within each subject. At least 15-20 min of rest was provided between each experimental sequence. Measures of brachial artery blood velocity and mean arterial pressure (MAP) were continuously recorded throughout each experimental sequence.
Brachial artery and deep vein catheterization
An indwelling 4.5-cm, 20-gauge Teflon catheter (model RA-04020 ARROW International, Reading, PA, USA) was placed in the brachial artery through the antecubital fossa of the exercising arm using aseptic techniques after local anaesthesia (1% lidocaine). The catheter was connected to a three-port connector in series, as previously described (Dietz et al. 1994; Casey et al. 2013b) . In brief, one port was connected to a pressure transducer (model PX600F, Edwards Lifescience, Irvine, CA, USA), which was positioned at the level of the heart to allow measurement of arterial pressure and was continuously flushed (3 ml/h) with saline using a stop-cock system to enable arterial blood sampling. The remaining two ports allowed arterial drug administration. A 4.8-cm, 20-gauge catheter (BD Insyte Autogard; Beckton+ Dickinson Infusion Therapy Systems, Inc., Sandy, UT, USA) was inserted in retrograde fashion into a deep vein in the antecubital fossa of the exercising arm. Confirmation that a selected deep vein drained the active forearm muscle was obtained via ultrasound imaging prior to catheterization by skilled anaesthesiologists. Saline was continuously infused through the catheter at approximately 1-2 ml/min for the duration of the study to keep the catheter patent.
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Forearm contraction protocol
At the beginning of the study, and prior to experimental trials, maximal voluntary contraction (MVC) was measured by having subjects squeeze a handgrip dynamometer (Stoelting, Chicago, IL, USA) at maximal effort three separate times and averaging the values that were within 2 kg of each other. The averaged MVC was then used to calculate a relative workload of 20% MVC for the forearm exercise trials. In addition, an absolute workload (7 kg) was used, as evidence suggests that inhibition of sympathetic adrenergic receptor vasoconstriction in the exercising muscle may be more closely associated with the mechanical cost of contractions (absolute work) performed and, therefore, related to the rate of oxidative metabolism, as opposed to other confounding factors, such as relative workloads, age, sex or training status (Wray et al. 2004 (Wray et al. , 2009 Brothers et al. 2006) . Rhythmic, forearm exercise was conducted by squeezing and releasing two handles together that were 4 cm apart on a custom-built, handgrip device attached to a simple pulley system. Forearm contractions were completed at 20 contractions/min, which were controlled by a metronome (1:2 s duty cycle). Subjects were cued to contract at the sound of the beat on the metronome and release the weight, without the intent to contract upon descent, when the metronome went silent during the relaxation phase.
Measurement of forearm blood flow
Brachial artery diameter and blood velocity were determined with a 12-MHz linear-array Doppler probe (model M12L; Vivid 7, General Electric, Milwaukee, WI, USA) with a probe insonation angle kept at 60°. Velocity waveforms were synchronized to a data acquisition system (WinDaq; DATAQ Instruments, Akron, OH, USA) through a Doppler audio transformer (Herr et al. 2010) . End-diastolic brachial artery diameter measurements were obtained at rest, at the end of SS conditions, and SS with α-agonist administration (SS + Infusion). Forearm blood flow (FBF, ml/min) was calculated as the product of mean blood velocity (cm/s) and brachial artery cross-sectional area (cm 2 ). Forearm vascular conductance (FVC, ml/min/100 mmHg) was calculated as the quotient of FBF and MAP.
Intra-arterial drug administration
Propranolol (a non-specific β-adrenergic blocker) was administered via the brachial artery throughout the 
. Experimental design
After instrumentation of the brachial artery catheter, subjects received propranolol to inhibit β-adrenergic receptors within the forearm throughout the duration of the experimental testing day. Experimental trials consisted first of rest trials (randomized within condition) followed by high flow control with adenosine (ADO) infusion and exercise conditions of either a relative (20% MVC) or absolute (7 kg) forearm handgrip intensity all of which were randomized (within and between conditions). Forearm blood flow (FBF) was measured for 2 min of baseline during each trial. After baseline or 3 min of the stimulus (adenosine or exercise) 'steady-state' (SS) FBF was calculated and a dose of phenylephrine (PE; α 1 -adrenergic receptor agonist) and dexmedetomidine (DEX; α 2 -adrenergic receptor agonist) were administered during the last 3 min of each trial in order to achieve a SS vasoconstrictor state. Forearm arterial and venous blood samples were taken in a period of 30 s at the end of SS exercise and SS+Infusion to determine blood gas variables of oxygen consumption and arterio-venous oxygen difference study to block any binding of the α-agonists to β-adrenergic receptors (Torp et al. 2001) and to minimize β-adrenergic-mediated vasodilatation during forearm exercise, as demonstrated in YW (Limberg et al. 2010) . Propranolol was infused as a 5-min loading dose (20 μg/min/dl tissue), followed by a maintenance dose (25 μg/min) for the duration of the experimental session (rest, exercise and high flow trials) (Wilkins et al. 2008; Casey et al. 2011) .
The selective α 1 agonist PE and selective α 2 agonist DEX were administered via the brachial artery for the final 3 min of each rest, high flow and exercise trial to determine α-adrenergic vasoconstrictor responsiveness. Specifically, PE was infused at 0.0625 μg/min/dl tissue and DEX infused at 12.5 ng/min/dl tissue (Kirby et al. 2011) . To normalize the concentration of each drug in the blood perfusing the forearm, the infusions were adjusted based on FBF and forearm volume (measured via water displacement).
ADO was used to pharmacologically elevate resting FBF independent of forearm contractions to create a 'high flow' control state. A single dose of 6.25 μg/min/dl tissue for 6 min was used (Dinenno et al. 2005) to create a 'passive high flow' control condition in order to compare against FBF and FVC responses from the exercise trials.
Blood sampling
A single arterial and venous blood sample (ß3 ml) was taken during the last 30 s of SS-exercise and SS-exercise with α-agonist administration (both α 1 and α 2 ; Fig. 1) . A blood-gas analyser (RadiometerLive, ABL 80 FLEX CO-OX, Brønshøj, Denmark) was used to immediately analyse the following arterial and venous partial pressures: carbon dioxide, oxygen, oxygen content, haemoglobin content and oxygen saturation. Subsequently, all pertinent gas samples were used to determine arterial-venous O 2 difference (a-vO 2diff ). From a-vO 2diff and exercising FBF, muscle O 2 consumption (VO 2m ) was determined.
Data acquisition and analysis. Data were collected at 250 Hz, stored on a computer, and analysed off-line with signal processing software (WinDaq). All haemodynamic measurements within each trial were determined by averaging values during the last 30 s of rest, SS-high flow or SS-exercise (during the third minute of exercise), and SS-high flow or SS-exercise with α-agonist administration (the sixth minute of ADO infusion or exercise). MAP was determined from the brachial artery pressure waveforms. Of particular interest were FBF and FVC responses measured at various 'SS' time points. The change in per cent FVC (%FVC) that occurred during α-agonist administration relative to rest, SS-adenosine or SS exercise among trials was calculated based on the following equation;
% FVC was used as the standard index to compare vasoconstrictor responses to α-agonist-induced vasoconstriction across trials in accordance with previous research (Dinenno et al. 2002 (Dinenno et al. , 2005 Smith et al. 2007; Kirby et al. 2008; Casey et al. 2013aa ).
Statistical analysis. All values are expressed as mean ± standard error of the mean (SEM). The primary analysis was to test whether vasoconstriction resulting from infusion of α-adrenergic agonists differs with age (YM vs. PMW) within each rest or exercise experimental condition (SS vs. SS+Infusion). The main dependent variables were FBF and FVC, which are represented as absolute values during SS-exercise and infusion conditions. Postjunctional α-adrenergic vasoconstriction (both α 1 and α 2 ) was analysed separately between each rest, high flow (ADO) and exercise intensity (relative, 20%; or absolute, 7 kg) trials. Haemodynamic variables (FBF, FVC, MAP), vasoconstrictor responsiveness (%FVC), and blood gas variables for each trial (rest, ADO, 20% and 7 kg) were compared using repeated measures (RM) ANOVA to test significance within (baseline vs. SS vs. SS+Infusion) and between groups (YW vs. PMW). If a significant interaction was detected, Tukey's post hoc pairwise comparisons were performed. Comparisons for baseline subject anthropometric characteristics were performed using unpaired t-tests. Furthermore, comparisons of FBF, FVC and %FVC between rest and exercise, as well as the SS responses between ADO (control) and exercise (20% and 7 kg) were performed using ANOVA. All statistical analyses were performed using SigmaPlot software. Statistical differences were set a priori at P < 0.05.
Results
Table 1 displays the subject characteristics and resting systemic haemodynamics prior to propranolol infusion for YW and older PMW. The mean age difference between the YW and older PMW was 41 years (P < 0.05). There were no significant group differences in body mass index, forearm volume, maximum handgrip strength, and resting heart rate, and systolic and diastolic blood pressure.
Peripheral vascular responses during rest, adenosine infusion and handgrip exercise
Resting and SS forearm haemodynamics and diameters are presented in Tables 2 and 3 . There were no differences J Physiol 596.13 in resting or SS diameters between YW and PMW. During the rest trial, infusion of PE (Table 2 ) and DEX (Table 3) significantly reduced FBF and FVC (main effect of time, P < 0.05) compared with baseline; however, there were no differences between age groups. ADO infusion increased FBF and FVC (main effect of time, P < 0.05) in both YW and PMW and this effect was similar with age. During forearm exercise (20% and 7 kg) the increase in SS-FBF and FVC was similar with age between PE and DEX conditions. However, there was an age × time interaction (P < 0.05) during SS exercises with PE infusion such that older PMW exhibited a reduced FBF and FVC response, whereas no changes were present in YW. However, while DEX infusion reduced FBF and FVC from SS to SS+DEX infusion during each trial (main effect of time; P < 0.05) these responses occurred to a similar extent between YW and PMW.
Vasoconstrictor responses to PE (α 1 -adrenergic receptor stimulation)
The vasoconstrictor responses to PE during rest and high flow trials were similar in older PMW and YW (Fig. 2) . The vasoconstrictor responses to PE during 7 kg and 20% MVC exercise conditions were blunted compared with the responses during rest and high flow trials in both YW (7 kg and 20%; all P < 0.001) and older PMW (7 kg and 20% MVC: all P < 0.001). However, the amount of vasoconstriction with PE during both absolute (7 kg; P < 0.05) and relative (20%; P < 0.05) exercise was greater in PMW than YW. 94 ± 2 9 3± 3 9 3± 1 9 3± 2 9 4± 1 9 4± 4 9 3± 1 9 3± 3 SS --93 ± 1 9 4± 2 9 6± 1 9 8± 3 9 7± 2 9 7± 3 SS+Infusion 95 ± 1 9 4± 3 9 5± 1 † 97 Data are presented as means ± SEM. SS, steady state without drug infusion; SS+Infusion, steady state with drug infusion; FBF, forearm blood flow, FVC, forearm vascular conductance; MAP, mean arterial pressure; YW, young women; PMW, postmenopausal women. There was a significant interaction (RM ANOVA; age × time) and main effect of time for FBF and FVC during 20% and 7 kg exercise trials, * P < 0.05 vs. SS within older postmenopausal women. Main effect of time for MAP during adenosine, 20% and 7 kg trials, † P < 0.05 vs. Baseline. Main effect of time for FBF and FVC during rest and adenosine trials, ‡ P < 0.05 vs. baseline and SS. 94 ± 1 9 3± 3 9 1± 1 9 1± 2 9 4± 2 9 5± 3 9 4± 1 9 4± 3 SS --90 ± 1 9 1± 1 9 7± 2 9 9± 3 9 8± 1 9 8± 4 SS+Infusion 95 ± 1 9 5± 3 9 3± 1 † 95 
Vasoconstrictor responses to DEX (α 2 -adrenergic receptor stimulation)
As shown in Fig. 3 , the vasoconstrictor responses to DEX during rest and high flow trials were similar in older PMW (P = 0.75) and relative (P = 0.92) exercise conditions was similar between YW and PMW.
Forearm exercise blood gas variables Table 4 represents forearm arterial and venous blood gas variables during SS-exercise and during SS-exercise with each respective α-agonist infusion. Due to technical issues during blood gas measurements for one young woman the specific data for this individual were not included in the statistical analysis. Therefore, all blood gas data are compared and represented as young (YW: n = 7) and older PMW (n = 8). There was no significant interaction for arterial and venous partial pressures of oxygen content, VO 2m and a-vO 2diff during PE and DEX infusion among exercise trials.
Discussion
This is the first study, to our knowledge, to examine receptor-specific α-adrenergic-mediated vasoconstriction at rest and during exercise in PMW. The study demonstrates that contraction-mediated blunting of vasoconstriction is attenuated in PMW whereas vasoconstrictor responsiveness at rest remains intact within the forearms of PMW compared with YW. Moreover, our findings demonstrate that the attenuated sympatholysis in the contracting forearms of older PMW is specific to impaired modulation of postjunctional α 1 -but not α 2 -adrenergic-mediated vasoconstriction. Lastly, regardless of using relative or absolute forearm intensities, both intensities appear effective at modulating postjunctional α 1 -adrenergic responsiveness; however, PMW exhibited an impaired ability to reduce postjunctional α 1 -adrenergic vasoconstriction during both relative and absolute exercise trials relative to YW. Collectively, these findings advance our understanding of local neurovascular control at rest and during exercise with age in women.
Postjunctional α-adrenergic responsiveness during forearm exercise in PMW
It has been suggested that the age-related increase in blood pressure and decline in physical function are attributed to a greater inability to offset α-adrenergic vasoconstriction at rest and during exercise (i.e. greater impairment in functional sympatholysis) (Dinenno et al. 2002 (Dinenno et al. , 2005 Wray et al. 2009; Kirby et al. 2011; . Along these lines, postjunctional modulation of α-adrenergic vasoconstriction specific to both α 1 and α 2 receptors has been purported to be attenuated in the contracting forearms of older men (Dinenno et al. 2005; Kirby et al. 2011) . Furthermore, while prior evidence reported a reduced ability of hand-grip exercise to blunt sympathetic vasoconstriction during acute SNS stimulation in the exercising forearm of older, oestrogen-deficient PMW , methodological limitations precluded a definitive interpretation of the data as they pertained to which specific α-adrenergic receptor is responsible for the impaired sympatholysis. Moreover, Fadel et al. (2004) used lower body negative pressure, which does not directly interrogate the postjunctional α-adrenergic receptors and near-infrared spectroscopy measured muscle tissue oxygenation, which provides only an indirect estimate of blood flow and vasoconstrictor responsiveness during exercise. The present study thus extends previous findings by providing novel evidence that PMW demonstrate impaired functional sympatholysis that appears to be specific to the α 1 receptors. In addition, we report that while SS-FBF and FVC were reduced in PMW during α 1 -adrenergic stimulation, these values remained unchanged within the exercising forearms of YW (Table 2) . Previous evidence in animals highlights a differential functional distribution of postjunctional adrenergic receptors within locomotor muscles (as opposed to the cremaster muscle) in the mouse (Moore et al. 2010) . Specifically, α 1 receptors are located mainly on the larger, more proximal resistance vessels of cremaster muscles, whereas within locomotor muscles α 1 receptors exert greater vasoconstrictor control on the smaller, more distal resistance vessels (Moore et al. 2010) . However, whether the functional distribution of post-junctional alpha-adrenergic receptors of the female human forearm is similar to the male mouse cremaster or gluteus maximus skeletal muscle remains inconclusive. Lastly, it is possible that blood flow may be less effectively distributed within the exercising muscle of PMW, which could possibly result from attenuated vasoconstriction within less metabolically active regions and/or impaired dilatation within active muscle fibres (Proctor & Moore, 2012) .
Postjunctional α-adrenergic responsiveness at rest in the forearm of PMW Another important aim of the present study was to examine whether responsiveness to postjunctional α 1 -and α 2 -adrenergic receptor agonists under resting conditions are impaired in PMW. Previous studies have demonstrated under resting conditions that older males have a reduced vasoconstrictor responsiveness in the forearm and leg during intra-arterial infusion of non-selective (Hogikyan & Supiano, 1994) and selective (Dinenno et al. 2002) postjunctional α-adrenergic agonists when compared to young healthy males. However, to our knowledge this is the first study to examine the modulatory role of α 1 -and α 2 -adrenergic responsiveness within the arms of YW vs. PMW under resting conditions. Investigating α 1 -and α 2 -adrenergic responsiveness in PMW is important, because PMW experience a greater age-associated increase in SNS activity and vasoconstrictor tone as compared to ageing males (Moreau et al. 2003; Hart et al. 2009; Moreau & Ozemek, 2017) , which may explain why this population experiences greater cardiovascular morbidity and mortality than ageing males (Joyner et al. 2016; Moreau & Ozemek, 2017) . To this end, the present findings add to pre-existing evidence by demonstrating that postjunctional α 1 -and α 2 -adrenergic receptor responsiveness remains relatively intact within the ageing forearm of PMW at rest.
Role of sex hormones on the modulatory role of α-adrenergic receptor responsiveness in YW vs. PMW Given the apparent discrepancies of reported vasoconstrictor responsiveness in the present study's findings and prior work (Dinenno et al. 2005) , it is tempting to speculate that sex differences in the modulation of postjunctional α-adrenergic receptor activity at rest and during exercise exist in older adults. Indeed, the transition into menopause and the associated loss of oestrogen may alter how α-adrenergic receptors within the resistance vasculature are modulated (Hart et al. 2009; Hart & Charkoudian, 2014) . In support of this, vasoconstrictor responses to α-adrenergic stimulation have been hypothesized to be blunted in women compared to men because of direct actions of oestrogen on the endothelium and vascular smooth muscle (Hart et al. 2009; Hart & Charkoudian, 2014) . The influence of the female sex hormones on the postjunctional α-adrenergic receptors can further be emphasized by evidence demonstrating that YW appear to have an attenuated forearm vasoconstrictor response at rest and during exercise during the luteal phase (high oestradiol) than during the early follicular phase (low oestradiol) of their menstrual cycle (Freedman & Girgis, 2000) . Additionally, Limberg et al. (2010) found that during the early luteal phase, YW respond to the exogenous α 2 -adrenergic agonist clonidine with less vasoconstriction during forearm exercise compared to during the early follicular phase. Interestingly, in the present study we recruited YW who were in the early follicular phase of the menstrual cycle and found no age-associated difference in postjunctional α 2 responsiveness during forearm exercise. Given the findings of the present study and previous J Physiol 596.13 evidence (Hart et al. 2009; Hart & Charkoudian, 2014) , it could be speculated that the lack of a difference in α 2 -adrenergic-mediated vasoconstriction between YW and PMW during forearm exercise of the present study may be related to the lower levels of oestrogen associated with the early follicular stage, which may not allow for vasoconstriction to be offset to the same extent when compared to the luteal phase of the menstrual cycle.
Hyperaemic and vasodilatatory responses during SS exercise in YW vs. PMW An age-related impairment in exercising SS blood flow has been demonstrated within the forearm (Kirby et al. 2011) , as well as in the legs of older men and PMW (Proctor et al. 1998 (Proctor et al. , 2003 Poole et al. 2003; Parker et al. 2008; Ridout et al. 2010; Moore et al. 2015) . However, to our knowledge, no evidence has been presented on the hyperaemic and vasodilatatory responses during SS-exercise (without α-adrenergic stimulation) involving the upper extremities in YW vs. PMW. Therefore, the present study has also provided novel evidence demonstrating that SS-FBF and FVC during mild-to moderate-intensity forearm exercise prior to α-adrenergic stimulation are unchanged between YW and PMW. These findings are consistent with previous evidence in older men, demonstrating that low-intensity handgrip exercise resulted in no age-related differences in SS-FBF and FVC (Dinenno et al. 2005) . It should be noted that reductions in exercising vascular conductance prior to and after acute sympathetic stimulation are more robust in the legs (relative to the forearm) of older vs. young men (Pawelczyk & Levine, 2002; Proctor & Newcomer, 2006; Wray & Richardson, 2006) . Furthermore, our findings of no age-related difference in SS-FBF and FVC in the forearms of women appear to be in contrast to previous work in the leg where age-related differences during graded single leg knee extension exercise were observed (Parker et al. 2007aa,b) . Thus, our conclusion of no age-associated impairment in bulk SS muscle blood flow in the forearm of YW vs. PMW may not be applicable to the lower limbs with age in women.
Absolute vs. relative exercise intensity: postjunctional α-adrenergic vasoconstriction during exercise in PMW An important strength of the current study was that we have addressed both relative and absolute exercise intensities and its association with functional sympatholysis, as it has been hypothesized that distinct differences exist with regard to how 'work' is performed when investigating α-adrenergic vasoconstriction in young vs. older individuals during exercise (Wray et al. 2009 ). They demonstrated a greater PE-mediated vasoconstriction in the exercising legs of older compared to young males under relative (40% work rate max) exercise intensities, but no such differences were observed when the work rate was matched using the same absolute workload (10 W). The authors suggested that the large differences in relative workloads between young (50 ± 5 W) and older (28 ± 5 W) groups probably resulted in the older group becoming less susceptible to exercise-induced metabolic inhibition in the leg (impaired functional sympatholysis). This raises the possibility that the observed differences in leg α 1 sensitivity could be attributed to the fact that older subjects did not reach absolute work rates high enough to provoke full attenuation of this receptor group. The authors thus concluded that when comparing groups with differing exercise capacities, differences in exercise-induced inhibition of α 1 -adrenergic vasoconstriction between young and old (males) may therefore not be as pronounced as previously reported. However, in contrast to the findings by Wray et al. (2009) , Mortensen et al. (2012) , using a similar experimental design, demonstrated that both relative and absolute work intensities are similarly effective at modulating functional sympatholysis in the legs of young and older men. In light of these observations we revealed that under exercise conditions using the same absolute mechanical work (i.e. 7 kg) PE-induced sympathetic vasoconstriction occurred to a greater extent in PMW than in YW. Collectively our findings are interpreted to suggest that the level of sympatholysis appears to be attenuated regardless of using absolute or relative workloads within the exercising forearms of PMW. In addition, it should be noted that while the mean relative exercise intensity value was nearly identical between YW and PMW (Table 1) of the present study, the wide range of MVC values (19-40 kg) and, hence, relative intensities (20% MVC) still afforded us an opportunity to investigate whether differences in absolute vs. relative forearm exercise intensities modulate functional sympatholysis in PMW.
Experimental considerations
There are a few experimental considerations that warrant attention in the present study. Firstly, we recruited normotensive women and excluded PMW who were taking hormone replacement therapy, in an attempt to control for the potential confounding influences that each variable may play on vascular assessments. Therefore, the present findings may apply only to oestrogen-deficient, late postmenopausal women without a high cardiovascular disease risk factor burden or overt clinical disease. In addition, it is possible that PMW who are on hormone replacement therapy may exhibit an improved functional sympatholysis, as previous evidence postulates . Second, we used a forearm model to investigate the extent to which postjunctional α-adrenergic receptors modulate exercising blood flow, metabolic regulation and vascular tone in YW and PMW. The forearm model allows for the study of local circulatory and metabolic regulation during exercise without the confounding influence of systemic circulatory factors (e.g. cardiac output). Therefore, it can be concluded that the enhanced PE-induced vasoconstriction and blood flow observed in older PMW of the present study is attributed to an impaired local regulation of vascular tone with age. Nevertheless, limb differences exist in human vascular physiology, such that the legs exhibit a more robust hyperaemic response than the arms, at least in males (Proctor & Newcomer, 2006; Wray & Richardson, 2006) .
Conclusions
This study presents novel evidence demonstrating that PMW have a decreased ability to blunt α 1 -adrenergic vasoconstriction compared to YW during forearm exercise (i.e. impaired functional sympatholysis). However, postjunctional α-adrenergic responsiveness at rest does not appear to be affected within the forearms of ageing women. Furthermore, while SS blood flow and vascular conductance during forearm exercise are similar between YW and PMW, these responses are blunted during α 1 -adrenergic stimulation within the forearm of PMW vs. YW. Lastly, regardless of using relative or absolute forearm exercise intensity, both intensities appear effective at modulating sympatholysis in YW and PMW.
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